Sam Philip
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments 23
- Glaucoma and retinal disorders 11
-
- Diabetes Treatment and Management 15
- Diabetes Management and Research 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
- Diabetes Management and Education 8
-
- Retinal Imaging and Analysis 22
- Obstetrics and Gynecology top 5%
-
- Diabetes and associated disorders 9
Sam Philip
74 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Ophthalmology 1.3k
- Endocrinology, Diabetes and Metabolism 1.6k
- Radiology, Nuclear Medicine and Imaging 1.5k
- Health Information Management 126
- Obstetrics and Gynecology 212
Countries citing papers authored by Sam Philip
This map shows the geographic impact of Sam Philip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Philip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Philip more than expected).
Fields of papers citing papers by Sam Philip
This network shows the impact of papers produced by Sam Philip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Philip. The network helps show where Sam Philip may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sam Philip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 15 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 19 | |
| 14 | 2020 | 14 | |
| 15 | 2018 | 41 | |
| 16 | 2017 | 98 | |
| 17 | 2016 | 46 | |
| 18 | 2011 | 226 | |
| 19 | Manual vs. automated: the diabetic retinopathy screening debate | 2008 | 3 |
| 20 | 2006 | 3 |
About Sam Philip
Sam Philip is a scholar working on Ophthalmology, Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging, Nephrology and Aging, having authored 77 papers that have together received 4.2k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (23 papers), Retinal Imaging and Analysis (22 papers), Diabetes Treatment and Management (15 papers), Diabetes Management and Research (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Glaucoma and retinal disorders (11 papers), Diabetes and associated disorders (9 papers) and Diabetes Management and Education (8 papers). The work is most often cited by research in Ophthalmology (1.3k citations), Endocrinology, Diabetes and Metabolism (1.6k citations), Radiology, Nuclear Medicine and Imaging (1.5k citations), Health Information Management (126 citations) and Obstetrics and Gynecology (212 citations). Sam Philip has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Keith A. Goatman, Alan Fleming, Peter F. Sharp, Sarah H. Wild, Robert S. Lindsay, Graham Leese, Helen M. Colhoun, John McKnight, Naveed Sattar and John A. Olson. Their work appears in journals such as Diabetologia, British Journal of Ophthalmology, Diabetic Medicine, Diabetes Care and PLoS Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.